The Leading Platform for
Long Read Genomics
Transform raw long-read sequencing data into actionable insights — from structural variants to repeat regions — at scale for research, diagnostics and drug discovery.
A spin-off from:
Published in:
Our Platform covers variant detection, prioritization, interpretation and reporting.
The Lucid Advantage
Genomics X Multi-Omics
Our platform analyses the whole genome in combination with RNA Seq, Methylation and tissue-specific Epigenetics information.
3D Genome Architecture x TAD regions
Lucid is the only platform that calculates the 3D architecture of the Genome and unlocks deep insights of non-coding regions and the Dark Genome
Cutting edge Technology
AI Detection
High-quality detection methods that decrease false-positive structural variants by 81%, including DEL, DUP, INS and INV in comparison to other tools.
AI Prioritization
Disease-agnostic AI tool ranks over 80% of known pathogenic variants in the top 10. We also created a disease-specific scoring system with over 90% accuracy, it ensures precise prioritization for more reliable research outcomes.